Meyer Handelman Company’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q3
Sell
-6,950
Closed -$231K 195
2017
Q2
$231K Hold
6,950
0.01% 185
2017
Q1
$223K Buy
+6,950
New +$223K 0.01% 184
2016
Q4
Sell
-7,450
Closed -$343K 189
2016
Q3
$343K Hold
7,450
0.02% 167
2016
Q2
$374K Hold
7,450
0.02% 162
2016
Q1
$399K Hold
7,450
0.02% 165
2015
Q4
$489K Hold
7,450
0.02% 155
2015
Q3
$421K Hold
7,450
0.02% 158
2015
Q2
$440K Buy
7,450
+600
+9% +$35.4K 0.02% 160
2015
Q1
$427K Hold
6,850
0.02% 162
2014
Q4
$394K Hold
6,850
0.02% 165
2014
Q3
$368K Hold
6,850
0.02% 164
2014
Q2
$359K Hold
6,850
0.02% 163
2014
Q1
$362K Hold
6,850
0.02% 161
2013
Q4
$275K Buy
6,850
+600
+10% +$24.1K 0.01% 176
2013
Q3
$236K Hold
6,250
0.01% 176
2013
Q2
$245K Buy
+6,250
New +$245K 0.01% 170